These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940 [TBL] [Abstract][Full Text] [Related]
23. Residual neuromuscular block in type II diabetes mellitus after rocuronium: a prospective observational study. Armendáriz-Buil I; Lobato-Solores F; Aguilera-Celorrio L; Morros-Díaz E; Fraile-Jiménez E; Vera-Bella J Eur J Anaesthesiol; 2014 Aug; 31(8):411-6. PubMed ID: 24201596 [TBL] [Abstract][Full Text] [Related]
24. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial. Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520 [TBL] [Abstract][Full Text] [Related]
25. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation. Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018 [TBL] [Abstract][Full Text] [Related]
26. Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin. Hasfurther DL; Bailey PL Can J Anaesth; 1996 Jun; 43(6):617-20. PubMed ID: 8773869 [TBL] [Abstract][Full Text] [Related]
34. Anaphylaxis to rocuronium. Thomas R; Wood M Anaesthesia; 2003 Feb; 58(2):196. PubMed ID: 12562431 [No Abstract] [Full Text] [Related]
35. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same. Mertes PM; Volcheck GW Anesthesiology; 2015 Jan; 122(1):5-7. PubMed ID: 25383569 [No Abstract] [Full Text] [Related]
36. Sugammadex and rocuronium-induced anaphylaxis. Wordsworth HI; Raja Y; Harrison S Br J Anaesth; 2011 Jun; 106(6):911-2. PubMed ID: 21576105 [No Abstract] [Full Text] [Related]
37. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation. Carron M; Ori C Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433 [No Abstract] [Full Text] [Related]
38. An Evaluation of Continuous Infusion Rocuronium for Sustained Neuromuscular Blockade in Critically Ill Adults. Groetzinger LM; Hutchins AT; Rivosecchi RM Ann Pharmacother; 2021 Jun; 55(6):732-737. PubMed ID: 33043678 [TBL] [Abstract][Full Text] [Related]
39. Early skin and challenge testing after rocuronium anaphylaxis. Schulberg EM; Webb AR; Kolawole H Anaesth Intensive Care; 2016 May; 44(3):425-7. PubMed ID: 27246945 [TBL] [Abstract][Full Text] [Related]
40. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]